Connection

Narendra Vyavahare to Animals

This is a "connection" page, showing publications Narendra Vyavahare has written about Animals.
Connection Strength

1.569
  1. Targeted delivery of pentagalloyl glucose inhibits matrix metalloproteinase activity and preserves elastin in emphysematous lungs. Respir Res. 2021 Sep 18; 22(1):249.
    View in: PubMed
    Score: 0.058
  2. Reversal of elastase-induced abdominal aortic aneurysm following the delivery of nanoparticle-based pentagalloyl glucose (PGG) is associated with reduced inflammatory and immune markers. Eur J Pharmacol. 2021 Nov 05; 910:174487.
    View in: PubMed
    Score: 0.058
  3. Osteoclast-Mediated Cell Therapy as an Attempt to Treat Elastin Specific Vascular Calcification. Molecules. 2021 Jun 15; 26(12).
    View in: PubMed
    Score: 0.057
  4. Systemic delivery of targeted nanotherapeutic reverses angiotensin II-induced abdominal aortic aneurysms in mice. Sci Rep. 2021 04 21; 11(1):8584.
    View in: PubMed
    Score: 0.056
  5. Nanoparticle-based targeted delivery of pentagalloyl glucose reverses elastase-induced abdominal aortic aneurysm and restores aorta to the healthy state in mice. PLoS One. 2020; 15(3):e0227165.
    View in: PubMed
    Score: 0.052
  6. Gold nanoparticles that target degraded elastin improve imaging and rupture prediction in an AngII mediated mouse model of abdominal aortic aneurysm. Theranostics. 2019; 9(14):4156-4167.
    View in: PubMed
    Score: 0.049
  7. Site-specific chelation therapy with EDTA-loaded albumin nanoparticles reverses arterial calcification in a rat model of chronic kidney disease. Sci Rep. 2019 02 22; 9(1):2629.
    View in: PubMed
    Score: 0.048
  8. Pentagalloyl glucose increases elastin deposition, decreases reactive oxygen species and matrix metalloproteinase activity in pulmonary fibroblasts under inflammatory conditions. Biochem Biophys Res Commun. 2018 04 30; 499(1):24-29.
    View in: PubMed
    Score: 0.045
  9. Fixation of Bovine Pericardium-Based Tissue Biomaterial with Irreversible Chemistry Improves Biochemical and Biomechanical Properties. J Cardiovasc Transl Res. 2017 Apr; 10(2):194-205.
    View in: PubMed
    Score: 0.042
  10. Systemic Delivery of Nanoparticles Loaded with Pentagalloyl Glucose Protects Elastic Lamina and Prevents Abdominal Aortic Aneurysm in Rats. J Cardiovasc Transl Res. 2016 12; 9(5-6):445-455.
    View in: PubMed
    Score: 0.041
  11. Reversal of Vascular Calcification and Aneurysms in a Rat Model Using Dual Targeted Therapy with EDTA- and PGG-Loaded Nanoparticles. Theranostics. 2016; 6(11):1975-1987.
    View in: PubMed
    Score: 0.041
  12. Prevention of abdominal aortic aneurysm progression by targeted inhibition of matrix metalloproteinase activity with batimastat-loaded nanoparticles. Circ Res. 2015 Nov 06; 117(11):e80-9.
    View in: PubMed
    Score: 0.038
  13. A novel crosslinking method for improved tear resistance and biocompatibility of tissue based biomaterials. Biomaterials. 2015 Oct; 66:83-91.
    View in: PubMed
    Score: 0.038
  14. Rat aortic smooth muscle cells cultured on hydroxyapatite differentiate into osteoblast-like cells via BMP-2-SMAD-5 pathway. Calcif Tissue Int. 2015 Apr; 96(4):359-69.
    View in: PubMed
    Score: 0.037
  15. Targeted chelation therapy with EDTA-loaded albumin nanoparticles regresses arterial calcification without causing systemic side effects. J Control Release. 2014 Dec 28; 196:79-86.
    View in: PubMed
    Score: 0.036
  16. Nanoparticle targeting to diseased vasculature for imaging and therapy. Nanomedicine. 2014 Jul; 10(5):1003-12.
    View in: PubMed
    Score: 0.034
  17. Hydroxyapatite and calcified elastin induce osteoblast-like differentiation in rat aortic smooth muscle cells. Exp Cell Res. 2014 Apr 15; 323(1):198-208.
    View in: PubMed
    Score: 0.034
  18. Elasto-regenerative properties of polyphenols. Biochem Biophys Res Commun. 2014 Feb 07; 444(2):205-11.
    View in: PubMed
    Score: 0.034
  19. Efficacy of reversal of aortic calcification by chelating agents. Calcif Tissue Int. 2013 Nov; 93(5):426-35.
    View in: PubMed
    Score: 0.033
  20. High-glucose levels and elastin degradation products accelerate osteogenesis in vascular smooth muscle cells. Diab Vasc Dis Res. 2013 Sep; 10(5):410-9.
    View in: PubMed
    Score: 0.032
  21. Neomycin and carbodiimide crosslinking as an alternative to glutaraldehyde for enhanced durability of bioprosthetic heart valves. J Biomater Appl. 2013 May; 27(8):948-60.
    View in: PubMed
    Score: 0.029
  22. Porcine vena cava as an alternative to bovine pericardium in bioprosthetic percutaneous heart valves. Biomaterials. 2012 Jan; 33(1):1-8.
    View in: PubMed
    Score: 0.029
  23. Neomycin enhances extracellular matrix stability of glutaraldehyde crosslinked bioprosthetic heart valves. J Biomed Mater Res B Appl Biomater. 2011 Nov; 99(2):217-29.
    View in: PubMed
    Score: 0.028
  24. Neomycin fixation followed by ethanol pretreatment leads to reduced buckling and inhibition of calcification in bioprosthetic valves. J Biomed Mater Res B Appl Biomater. 2010 Jan; 92(1):168-77.
    View in: PubMed
    Score: 0.026
  25. In vivo vascular tissue engineering: influence of cytokine and implant location on tissue specific cellular recruitment. J Tissue Eng Regen Med. 2009 Jun; 3(4):280-9.
    View in: PubMed
    Score: 0.025
  26. The effect of glycosaminoglycan stabilization on tissue buckling in bioprosthetic heart valves. Biomaterials. 2008 Apr; 29(11):1645-53.
    View in: PubMed
    Score: 0.022
  27. Osteogenic responses in fibroblasts activated by elastin degradation products and transforming growth factor-beta1: role of myofibroblasts in vascular calcification. Am J Pathol. 2007 Jul; 171(1):116-23.
    View in: PubMed
    Score: 0.022
  28. Elastin stabilization for treatment of abdominal aortic aneurysms. Circulation. 2007 Apr 03; 115(13):1729-37.
    View in: PubMed
    Score: 0.021
  29. Neomycin prevents enzyme-mediated glycosaminoglycan degradation in bioprosthetic heart valves. Biomaterials. 2007 Jun; 28(18):2861-8.
    View in: PubMed
    Score: 0.021
  30. In vivo cellular repopulation of tubular elastin scaffolds mediated by basic fibroblast growth factor. Biomaterials. 2007 Jun; 28(18):2830-8.
    View in: PubMed
    Score: 0.021
  31. Toward cell therapy for vascular calcification: osteoclast-mediated demineralization of calcified elastin. Cardiovasc Pathol. 2007 Jan-Feb; 16(1):29-37.
    View in: PubMed
    Score: 0.021
  32. Glycosaminoglycan-targeted fixation for improved bioprosthetic heart valve stabilization. Biomaterials. 2007 Jan; 28(3):496-503.
    View in: PubMed
    Score: 0.020
  33. Structural requirements for stabilization of vascular elastin by polyphenolic tannins. Biomaterials. 2006 Jul; 27(19):3645-51.
    View in: PubMed
    Score: 0.020
  34. Elastin calcification in the rat subdermal model is accompanied by up-regulation of degradative and osteogenic cellular responses. Am J Pathol. 2006 Feb; 168(2):490-8.
    View in: PubMed
    Score: 0.020
  35. Stability and function of glycosaminoglycans in porcine bioprosthetic heart valves. Biomaterials. 2006 Mar; 27(8):1507-18.
    View in: PubMed
    Score: 0.019
  36. Elastin-derived peptides and TGF-beta1 induce osteogenic responses in smooth muscle cells. Biochem Biophys Res Commun. 2005 Aug 26; 334(2):524-32.
    View in: PubMed
    Score: 0.019
  37. Novel capillary channel fiber scaffolds for guided tissue engineering. Acta Biomater. 2005 Nov; 1(6):607-14.
    View in: PubMed
    Score: 0.019
  38. Biocompatibility and remodeling potential of pure arterial elastin and collagen scaffolds. Biomaterials. 2006 Feb; 27(5):702-13.
    View in: PubMed
    Score: 0.019
  39. Tannic acid treatment enhances biostability and reduces calcification of glutaraldehyde fixed aortic wall. Biomaterials. 2005 Apr; 26(11):1237-45.
    View in: PubMed
    Score: 0.018
  40. Elastin degradation and calcification in an abdominal aorta injury model: role of matrix metalloproteinases. Circulation. 2004 Nov 30; 110(22):3480-7.
    View in: PubMed
    Score: 0.018
  41. Novel porous aortic elastin and collagen scaffolds for tissue engineering. Biomaterials. 2004 Oct; 25(22):5227-37.
    View in: PubMed
    Score: 0.018
  42. Elastin stabilization in cardiovascular implants: improved resistance to enzymatic degradation by treatment with tannic acid. Biomaterials. 2004 Jul; 25(16):3293-302.
    View in: PubMed
    Score: 0.017
  43. Involvement of matrix metalloproteinases and tenascin-C in elastin calcification. Cardiovasc Pathol. 2004 May-Jun; 13(3):146-55.
    View in: PubMed
    Score: 0.017
  44. Extracellular matrix degrading enzymes are active in porcine stentless aortic bioprosthetic heart valves. J Biomed Mater Res A. 2003 Sep 15; 66(4):755-63.
    View in: PubMed
    Score: 0.017
  45. Role of elastin in pathologic calcification of xenograft heart valves. J Biomed Mater Res A. 2003 Jul 01; 66(1):93-102.
    View in: PubMed
    Score: 0.016
  46. Glycosaminoglycan-degrading enzymes in porcine aortic heart valves: implications for bioprosthetic heart valve degeneration. J Heart Valve Dis. 2003 Mar; 12(2):217-25.
    View in: PubMed
    Score: 0.016
  47. Degeneration of bioprosthetic heart valve cusp and wall tissues is initiated during tissue preparation: an ultrastructural study. J Heart Valve Dis. 2003 Mar; 12(2):226-34.
    View in: PubMed
    Score: 0.016
  48. Pentagalloyl Glucose (PGG) Prevents and Restores Mechanical Changes Caused by Elastic Fiber Fragmentation in the Mouse Ascending Aorta. Ann Biomed Eng. 2023 Apr; 51(4):806-819.
    View in: PubMed
    Score: 0.016
  49. Aluminum chloride pretreatment of elastin inhibits elastolysis by matrix metalloproteinases and leads to inhibition of elastin-oriented calcification. Am J Pathol. 2001 Dec; 159(6):1981-6.
    View in: PubMed
    Score: 0.015
  50. Inhibition of matrix metalloproteinase activity attenuates tenascin-C production and calcification of implanted purified elastin in rats. Am J Pathol. 2000 Sep; 157(3):885-93.
    View in: PubMed
    Score: 0.013
  51. Targeted Gold Nanoparticles as an Indicator of Mechanical Damage in an Elastase Model of Aortic Aneurysm. Ann Biomed Eng. 2020 Aug; 48(8):2268-2278.
    View in: PubMed
    Score: 0.013
  52. Elastin calcification and its prevention with aluminum chloride pretreatment. Am J Pathol. 1999 Sep; 155(3):973-82.
    View in: PubMed
    Score: 0.013
  53. Mechanisms of bioprosthetic heart valve failure: fatigue causes collagen denaturation and glycosaminoglycan loss. J Biomed Mater Res. 1999 Jul; 46(1):44-50.
    View in: PubMed
    Score: 0.012
  54. Prevention of calcification of glutaraldehyde-crosslinked porcine aortic cusps by ethanol preincubation: mechanistic studies of protein structure and water-biomaterial relationships. J Biomed Mater Res. 1998 Jun 15; 40(4):577-85.
    View in: PubMed
    Score: 0.012
  55. Prevention of bioprosthetic heart valve calcification by ethanol preincubation. Efficacy and mechanisms. Circulation. 1997 Jan 21; 95(2):479-88.
    View in: PubMed
    Score: 0.010
  56. Nitric oxide stimulates matrix synthesis and deposition by adult human aortic smooth muscle cells within three-dimensional cocultures. Tissue Eng Part A. 2015 Apr; 21(7-8):1455-70.
    View in: PubMed
    Score: 0.009
  57. On the biomechanical role of glycosaminoglycans in the aortic heart valve leaflet. Acta Biomater. 2013 Jan; 9(1):4653-60.
    View in: PubMed
    Score: 0.008
  58. Synthesis and characterization of biodegradable elastomeric polyurethane scaffolds fabricated by the inkjet technique. Biomaterials. 2008 Oct; 29(28):3781-91.
    View in: PubMed
    Score: 0.006
  59. Effects of collagen fiber orientation on the response of biologically derived soft tissue biomaterials to cyclic loading. J Biomed Mater Res A. 2007 Jan; 80(1):194-205.
    View in: PubMed
    Score: 0.005
  60. Triglycidylamine crosslinking of porcine aortic valve cusps or bovine pericardium results in improved biocompatibility, biomechanics, and calcification resistance: chemical and biological mechanisms. Am J Pathol. 2005 Jan; 166(1):1-13.
    View in: PubMed
    Score: 0.005
  61. Response of heterograft heart valve biomaterials to moderate cyclic loading. J Biomed Mater Res A. 2004 Jun 15; 69(4):658-69.
    View in: PubMed
    Score: 0.004
  62. Inhibition of cusp and aortic wall calcification in ethanol- and aluminum-treated bioprosthetic heart valves in sheep: background, mechanisms, and synergism. J Heart Valve Dis. 2003 Mar; 12(2):209-16; discussion 216.
    View in: PubMed
    Score: 0.004
  63. Prevention of glutaraldehyde-fixed bioprosthetic heart valve calcification by alcohol pretreatment: further mechanistic studies. J Heart Valve Dis. 2000 Jul; 9(4):561-6.
    View in: PubMed
    Score: 0.003
  64. Identification and characterization of calcifying valve cells from human and canine aortic valves. J Heart Valve Dis. 1999 May; 8(3):254-60.
    View in: PubMed
    Score: 0.003
  65. Inhibition of aortic wall calcification in bioprosthetic heart valves by ethanol pretreatment: biochemical and biophysical mechanisms. J Biomed Mater Res. 1998 Oct; 42(1):30-7.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.